Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Mol Genet ; 21(11): 2559-71, 2012 Jun 01.
Article in English | MEDLINE | ID: mdl-22388933

ABSTRACT

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dystrophin gene that result in the absence of functional protein. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD and recent clinical trials have demonstrated encouraging results. However, antisense oligonucleotide-mediated exon skipping for DMD still faces major hurdles such as extremely low efficacy in the cardiac muscle, poor cellular uptake and relatively rapid clearance from circulation, which means that repeated administrations are required to achieve some therapeutic efficacy. To overcome these limitations, we previously proposed the use of small nuclear RNAs (snRNAs), especially U7snRNA to shuttle the antisense sequences after vectorization into adeno-associated virus (AAV) vectors. In this study, we report for the first time the efficiency of the AAV-mediated exon skipping approach in the utrophin/dystrophin double-knockout (dKO) mouse which is a very severe and progressive mouse model of DMD. Following a single intravenous injection of scAAV9-U7ex23 in dKO mice, near-normal levels of dystrophin expression were restored in all muscles examined, including the heart. This resulted in a considerable improvement of their muscle function and dystrophic pathology as well as a remarkable extension of the dKO mice lifespan. These findings suggest great potential for AAV-U7 in systemic treatment of the DMD phenotype.


Subject(s)
Dependovirus/genetics , Dystrophin/genetics , Exons , Muscular Dystrophy, Duchenne/genetics , Muscular Dystrophy, Duchenne/therapy , RNA, Small Nuclear/genetics , Utrophin/genetics , Animals , Dependovirus/metabolism , Disease Models, Animal , Dystrophin/metabolism , Genetic Therapy , Mice , Muscular Dystrophy, Duchenne/pathology , Phenotype , RNA, Small Nuclear/therapeutic use , Utrophin/metabolism
2.
Mol Ther ; 20(6): 1212-21, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22354379

ABSTRACT

Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disorder caused by mutations in the dystrophin gene. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD but still faces personalized medicine challenges as different mutations found in DMD patients require skipping of different exons. However, 70% of DMD patients harbor dystrophin gene deletions in a mutation-rich area or "hot-spot" in the central genomic region. In this study, we have developed 11 different U7 small-nuclear RNA, to shuttle antisense sequences designed to mask key elements involved in the splicing of exons 45 to 55. We demonstrate that these constructs induce efficient exon skipping both in vitro in DMD patients' myoblasts and in vivo in human DMD (hDMD) mice and that they can be combined into a single vector to achieve a multi skipping of at least 3 exons. These very encouraging results provide proof of principle that efficient multiexon-skipping can be achieved using adeno-associated viral (AAV) vectors encoding multiple U7 small-nuclear RNAs (U7snRNAs), offering therefore very promising tools for clinical treatment of DMD.


Subject(s)
Alternative Splicing , Dystrophin/genetics , Exons , Genetic Vectors , Muscular Dystrophy, Duchenne/genetics , RNA, Small Nuclear , Animals , Cell Line , DNA, Antisense , Dependovirus/genetics , Disease Models, Animal , Gene Order , Humans , Lentivirus/genetics , Mice , Mice, Transgenic , Muscular Dystrophy, Duchenne/therapy , Myoblasts/metabolism , Transduction, Genetic
3.
PLoS Biol ; 10(2): e1001256, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22346733

ABSTRACT

The visceral endoderm (VE) is a simple epithelium that forms the outer layer of the egg-cylinder stage mouse embryo. The anterior visceral endoderm (AVE), a specialised subset of VE cells, is responsible for specifying anterior pattern. AVE cells show a stereotypic migratory behaviour within the VE, which is responsible for correctly orientating the anterior-posterior axis. The epithelial integrity of the VE is maintained during the course of AVE migration, which takes place by intercalation of AVE and other VE cells. Though a continuous epithelial sheet, the VE is characterised by two regions of dramatically different behaviour, one showing robust cell movement and intercalation (in which the AVE migrates) and one that is static, with relatively little cell movement and mixing. Little is known about the cellular rearrangements that accommodate and influence the sustained directional movement of subsets of cells (such as the AVE) within epithelia like the VE. This study uses an interdisciplinary approach to further our understanding of cell movement in epithelia. Using both wild-type embryos as well as mutants in which AVE migration is abnormal or arrested, we show that AVE migration is specifically linked to changes in cell packing in the VE and an increase in multi-cellular rosette arrangements (five or more cells meeting at a point). To probe the role of rosettes during AVE migration, we develop a mathematical model of cell movement in the VE. To do this, we use a vertex-based model, implemented on an ellipsoidal surface to represent a realistic geometry for the mouse egg-cylinder. The potential for rosette formation is included, along with various junctional rearrangements. Simulations suggest that while rosettes are not essential for AVE migration, they are crucial for the orderliness of this migration observed in embryos. Our simulations are similar to results from transgenic embryos in which Planar Cell Polarity (PCP) signalling is disrupted. Such embryos have significantly reduced rosette numbers, altered epithelial packing, and show abnormalities in AVE migration. Our results show that the formation of multi-cellular rosettes in the mouse VE is dependent on normal PCP signalling. Taken together, our model and experimental observations suggest that rosettes in the VE epithelium do not form passively in response to AVE migration. Instead, they are a PCP-dependent arrangement of cells that acts to buffer the disequilibrium in cell packing generated in the VE by AVE migration, enabling AVE cells to migrate in an orderly manner.


Subject(s)
Cell Movement , Endoderm/cytology , Epithelial Cells/physiology , Algorithms , Animals , Cell Polarity , Computer Simulation , Embryo Culture Techniques , Embryo, Mammalian/cytology , Epithelial Cells/cytology , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Microscopy, Polarization , Models, Biological , Time-Lapse Imaging
4.
PLoS Biol ; 9(2): e1001019, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21364967

ABSTRACT

The anterior visceral endoderm (AVE), a signalling centre within the simple epithelium of the visceral endoderm (VE), is required for anterior-posterior axis specification in the mouse embryo. AVE cells migrate directionally within the VE, thereby properly positioning the future anterior of the embryo and orientating the primary body axis. AVE cells consistently come to an abrupt stop at the border between the anterior epiblast and extra-embryonic ectoderm, which represents an end-point to their proximal migration. Little is known about the underlying basis for this barrier and how surrounding cells in the VE respond to or influence AVE migration. We use high-resolution 3D reconstructions of protein localisation patterns and time-lapse microscopy to show that AVE cells move by exchanging neighbours within an intact epithelium. Cell movement and mixing is restricted to the VE overlying the epiblast, characterised by the enrichment of Dishevelled-2 (Dvl2) to the lateral plasma membrane, a hallmark of Planar Cell Polarity (PCP) signalling. AVE cells halt upon reaching the adjoining region of VE overlying the extra-embryonic ectoderm, which displays reduced neighbour exchange and in which Dvl2 is excluded specifically from the plasma membrane. Though a single continuous sheet, these two regions of VE show distinct patterns of F-actin localisation, in cortical rings and an apical shroud, respectively. We genetically perturb PCP signalling and show that this disrupts the localisation pattern of Dvl2 and F-actin and the normal migration of AVE cells. In Nodal null embryos, membrane localisation of Dvl2 is reduced, while in mutants for the Nodal inhibitor Lefty1, Dvl2 is ectopically membrane localised, establishing a role for Nodal in modulating PCP signalling. These results show that the limits of AVE migration are determined by regional differences in cell behaviour and protein localisation within an otherwise apparently uniform VE. In addition to coordinating global cell movements across epithelia (such as during convergence extension), PCP signalling in interplay with TGFß signalling can demarcate regions of differing behaviour within epithelia, thereby modulating the movement of cells within them.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Endoderm/cytology , Endoderm/metabolism , Nodal Protein/metabolism , Phosphoproteins/metabolism , Viscera/cytology , Actins/metabolism , Animals , Cadherins/metabolism , Cell Movement , Cell Polarity , Cell Shape , Dishevelled Proteins , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Epithelium/metabolism , Left-Right Determination Factors/metabolism , Membrane Proteins/metabolism , Mice , Models, Biological , Nonmuscle Myosin Type IIA/metabolism , Protein Transport , Signal Transduction , Viscera/embryology , Zonula Occludens-1 Protein
5.
Reproduction ; 128(1): 43-52, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15232063

ABSTRACT

Measurement of inhibins A and B in the serum of normal cyclic rodents has implicated FSH in the regulation of these peptides within the ovary. To extend these observations we have used a panel of mutant mice carrying mutations which affect either the production of, or the ability to respond to, FSH and LH. As a consequence, the females are infertile and show different degrees of follicular development. The aim of this study was to measure inhibin gene transcription in the ovaries of these mutant females together with inhibin protein levels in ovaries and serum and to relate these to follicular development within the ovary. Comparison was made with a pool of normal/heterozygous females. In hpg females where lack of GnRH production results in the absence of gonadotropin synthesis, in FSHbeta knockout (FSHbetaKO) females where disruption of the gene encoding FSHbeta results in the absence of FSH production, and in FSH receptor knockout (FSHRKO) females which are unable to respond to circulating FSH, follicular development remains at the pre-antral stage in these three mutants. Only in the hpg females were common inhibin alpha subunit mRNA levels significantly lower than normal. In these three mutants, however, mRNA levels for both the betaA and betaB subunits were extremely low compared with normal mice. At the protein level, neither inhibin A nor B was detected in the serum of these three mutants; however inhibin B, albeit at very low levels, was detectable within the ovaries. These observations confirm a major role for FSH in the control of transcription of the betaA and betaB genes but suggest that the constitutive transcription of the alpha subunit is less dependent on FSH. In contrast, in LH receptor knockout (LuRKO) female mice inhibin betaA subunit mRNA levels were similar to those measured in normal/heterozygous females but levels of inhibin alpha and betaB subunit mRNAs were significantly higher than in the normal group. This was reflected in significantly higher inhibin B protein levels in ovaries and serum. An inability to respond to LH combined with high circulating levels of FSH leads to a high proportion of antral follicles in LuRKO females, with granulosa cells constituting the major cell type within the ovary. The high percentage of antral granulosa cells is likely to account for the significantly higher levels of inhibin B production in these ovaries.


Subject(s)
Gonadotropin-Releasing Hormone/genetics , Gonadotropins, Pituitary/biosynthesis , Inhibin-beta Subunits/genetics , Ovary/metabolism , RNA, Messenger/metabolism , Animals , Female , Follicle Stimulating Hormone/biosynthesis , Follicle Stimulating Hormone/blood , Follicle Stimulating Hormone, beta Subunit/genetics , Gonadotropins, Pituitary/metabolism , Immunohistochemistry/methods , Inhibin-beta Subunits/analysis , Inhibin-beta Subunits/blood , Inhibins/analysis , Inhibins/blood , Inhibins/genetics , Luteinizing Hormone/biosynthesis , Luteinizing Hormone/blood , Mice , Mice, Knockout , Mice, Mutant Strains , Mutation , Ovarian Follicle/physiology , Ovary/chemistry , RNA, Messenger/analysis , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...